Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jarman

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
British Journal of Cancer|November 1, 1991
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patientsM Dowsett, F MacNeill, A Mehta, et al.
Journal of Medicinal Chemistry|December 1, 1981
5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomersA B Foster, M Jarman, R W Kinas, et al.
Journal of the Air & Waste Management Association (1995)|May 18, 2001
Exploratory studies of PM10 receptor and source profiling by GC/MS and principal component analysis of temporally and spatially resolved ambient samplesS J Jeon, H L Meuzelaar, S A Sheya, et al.
Journal of Wildlife Diseases|October 23, 2010
Persistent organic pollutants in the blood of free-ranging sea otters (Enhydra lutris ssp.) in Alaska and CaliforniaDavid A Jessup, Christine K Johnson, James Estes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancerB P Haynes, M Jarman, M Dowsett, et al.
Breast Cancer Research and Treatment|December 1, 1993
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancerS R Johnston, B P Haynes, N P Sacks, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 23, 2006
Albatross species demonstrate regional differences in North Pacific marine contaminationMyra Finkelstein, Bradford S Keitt, Donald A Croll, et al.
Journal of Chromatography|May 8, 1992
Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometryG K Poon, M Jarman, R McCague, et al.
Cancer Research|March 1, 1995
Idoxifene: report of a phase I study in patients with metastatic breast cancerR C Coombes, B P Haynes, M Dowsett, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
British Journal of Cancer|November 1, 1991
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patientsM Dowsett, F MacNeill, A Mehta, et al.
Journal of Medicinal Chemistry|December 1, 1981
5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomersA B Foster, M Jarman, R W Kinas, et al.
Journal of the Air & Waste Management Association (1995)|May 18, 2001
Exploratory studies of PM10 receptor and source profiling by GC/MS and principal component analysis of temporally and spatially resolved ambient samplesS J Jeon, H L Meuzelaar, S A Sheya, et al.
Journal of Wildlife Diseases|October 23, 2010
Persistent organic pollutants in the blood of free-ranging sea otters (Enhydra lutris ssp.) in Alaska and CaliforniaDavid A Jessup, Christine K Johnson, James Estes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancerB P Haynes, M Jarman, M Dowsett, et al.
Breast Cancer Research and Treatment|December 1, 1993
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancerS R Johnston, B P Haynes, N P Sacks, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 23, 2006
Albatross species demonstrate regional differences in North Pacific marine contaminationMyra Finkelstein, Bradford S Keitt, Donald A Croll, et al.
Journal of Chromatography|May 8, 1992
Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometryG K Poon, M Jarman, R McCague, et al.
Cancer Research|March 1, 1995
Idoxifene: report of a phase I study in patients with metastatic breast cancerR C Coombes, B P Haynes, M Dowsett, et al.
Pageof 19